Data as of Apr 17
| +0.74 / +0.62%|
The 2 analysts offering 12-month price forecasts for Bio-Rad Laboratories Inc have a median target of 140.50, with a high estimate of 150.00 and a low estimate of 131.00. The median estimate represents a +16.50% increase from the last price of 120.60.
The current consensus among 2 polled investment analysts is to Buy stock in Bio-Rad Laboratories Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.